TickerFacts.

Orthofix Medical Inc. (OFIX): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2010-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$65.85M
Year ended 2025-12-31
$61.41M
Trailing 12 months to 2026-06-30
+10.3%
3-year compound annual growth
+11.0%
5-year compound annual growth
+9.6%
10-year compound annual growth
$80.23M2009-12-31: $31.46M2010-12-31: $27.96M2011-12-31: $22.86M2012-12-31: $28.58M2013-12-31: $26.77M2014-12-31: $24.99M2015-12-31: $26.39M2016-12-31: $28.80M2017-12-31: $29.70M2018-12-31: $33.22M2019-12-31: $34.64M2020-12-31: $39.06M2021-12-31: $49.62M2022-12-31: $49.06M2023-12-31: $80.23M2024-12-31: $73.64M2025-12-31: $65.85M$65.85M
2009-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$65.85M-10.6%2026-02-24, From 2025-01-01
2024-12-31$73.64M-8.2%2026-02-24, From 2024-01-01
2023-12-31$80.23M+63.5%2026-02-24, From 2023-01-01
2022-12-31$49.06M-1.1%2025-02-25, From 2022-01-01
2021-12-31$49.62M+27.1%2024-03-05, From 2021-01-01
2020-12-31$39.06M+12.8%2023-03-06, From 2020-01-01
2019-12-31$34.64M+4.3%2022-02-25, From 2019-01-01
2018-12-31$33.22M+11.8%2021-02-26, From 2018-01-01
2017-12-31$29.70M+3.1%2020-02-24, From 2017-01-01
2016-12-31$28.80M+9.1%2019-02-25, From 2016-01-01
2015-12-31$26.39M+5.6%2018-02-26, From 2015-01-01
2014-12-31$24.99M-6.6%2017-02-27, From 2014-01-01
2013-12-31$26.77M-6.3%2016-02-29, From 2013-01-01
2012-12-31$28.58M+25.0%2015-04-29, From 2012-01-01
2011-12-31$22.86M-18.2%2015-03-31, From 2011-01-01
2010-12-31$27.96Mn/c2014-03-24, From 2010-01-01
2009-12-31$31.46Mn/a2012-02-29, From 2009-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Orthofix Medical Inc. (OFIX)2025-12-31$65.85M-10.6%
Alphatec Holdings, Inc. (ATEC)2025-12-31$76.27M-5.5%
iRhythm Holdings, Inc. (IRTC)2025-12-31$84.61M+18.4%
Inspire Medical Systems, Inc. (INSP)2025-12-31$103.17M-9.6%
Tandem Diabetes Care Inc (TNDM)2025-12-31$193.11M-2.9%
NovoCure Ltd (NVCR)2025-12-31$224.54M+7.1%
Embecta Corp. (EMBC)2025-09-30$37.30M-52.7%
UFP Technologies Inc (UFPT)2025-12-31$8.60M-17.3%
Bioventus Inc. (BVS)2025-12-31$12.11M-13.2%

Compare OFIX, ATEC, IRTC, INSP side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗